Study of Immune Globulin Intravenous (Human) GC5107 in Pediatric Subjects With Primary Humoral Immunodeficiency
Condition:   Primary Immune Deficiency Intervention:   Biological: GC5107 Sponsors:   Green Cross Corporation;   Atlantic Research Group Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 25, 2020 Category: Research Source Type: clinical trials